Shortage of GLP-1 receptor agonists While these therapeutic effects are beneficial for both diabetic and overweight patients, the weight loss effect has affected greatly the supply of these drugs
George Looking for Semaglutide, commonly known by its brand name Ozempic treatment options
Retatrutide is a weekly injectable weight loss medication currently being developed by Eli Lilly (the same company that makes Mounjaro) for the treatment of type 2 diabetes and obesity
To put that in perspective, this level of weight reduction is comparable to what can be seen after some forms of bariatric surgery, but achieved through a peptide-based therapy
There is no MHRA-approved, product-specific shelf life for reconstituted retatrutide, as it is not a licensed medicine in the UK
Step 1: Complete the Free Health Assessment The process begins with a detailed health quiz